Nevakar Enters $50 Million Product Financing Agreement with NovaQuest Capital for Continued Development of Injectable Products
BRIDGEWATER, N.J. and RALEIGH, N.C., June 18, 2019 (GLOBE NEWSWIRE) -- Nevakar Inc. (“Nevakar” or the “Company”), a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today that it recently entered …